Anderson Kenneth Carl - Insider Non-Derivative Transactions at C4 Therapeutics, Inc. (CCCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 1, 2024, Anderson Kenneth Carl's relationship to C4 Therapeutics, Inc. (CCCC) is Director, and currently has 114,671 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CCCC insiders.
Data Source: SEC.
Anderson Kenneth Carl - Insider Non-Derivative Transactions of CCCC Common Stock
Anderson Kenneth Carl - Insider Non-Derivative Transactions at CCCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 2, 2024 | Acquisition -- (Common Stock) | 2320 | 4.85 | 114671 |
| Apr 2, 2024 | Acquisition -- (Common Stock) | 1389 | 8.1 | 112351 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 1725 | 6.52 | 110962 |
| Oct 3, 2023 | Acquisition -- (Common Stock) | 6617 | 1.7 | 109237 |
| Jul 4, 2023 | Acquisition -- (Common Stock) | 3976 | 2.83 | 102620 |
| Apr 4, 2023 | Acquisition -- (Common Stock) | 3516 | 3.2 | 98644 |
| Jan 7, 2023 | M -- (Common Stock) | 268 | 2.11 | 94684 |
| Jan 7, 2023 | M -- (Common Stock) | 444 | 4.98 | 95128 |
| Jan 4, 2023 | Acquisition -- (Common Stock) | 1568 | 6.38 | 94416 |